Angiogenic factors could help us to define patients obtaining complete response with undetectable minimal residual disease in untreated CLL patients treated by FCR: results from the CLL2010FMP, a FILO study-Reference-Cited by-同舟云学术

Angiogenic factors could help us to define patients obtaining complete response with undetectable minimal residual disease in untreated CLL patients treated by FCR: results from the CLL2010FMP, a FILO study

Published:2021-11-10 Issue:13 Volume:62 Page:3160-3169
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Gagez Anne Laure¹,Paul Franciane²,Alaterre Elina³,Gouilleux-Gruart Valérie⁴,Tuaillon Edouard⁵,Lepretre Stéphane⁶,Ternant David⁷,Letestu Rémi⁸,Moreaux Jérôme⁹¹⁰¹¹^ORCID,Cartron Guillaume¹²¹³

Affiliation:

1. Department of Clinical Hematology, University Hospital Centre Montpellier, Montpellier, France

2. University Hospital Centre Montpellier, Montpellier, France

3. IGH, University of Montpellier, Montpellier, France

4. EA 7501, Université François Rabelais, Tours, France

5. Department of Bacteriology-Virology, University Hospital Centre Montpellier, Montpellier, France

6. Centre Henri Becquerel, Hematology, Rouen, France

7. UMR7292, Laboratory of Pharmacology-Toxicology, Tours, France

8. Department of Biological Hematology, Hospital Avicenne, Bobigny, France

9. IGH, Montpellier, France

10. Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, University Hospital Centre Montpellier, Montpellier, France

11. Institut Universitaire de France, Paris, France